Hormone Replacement Therapy for Men
The loss of men’s hormones is called “Andropause” or “Male Menopause”. It is sometimes referred to as low testosterone or “Low T.” Andropause generally affects men between the ages of 40 and 55, similar to menopause in women.
Andropause is simply a decline in a man’s level of testosterone, causing mood changes, decreased muscle mass, fatigue, and loss of sex drive. Other conditions related to complaints of fatigue may include low thyroid or adrenal function.
Andropause may cause any of these symptoms:
- Decreased muscle mass and strength
- Increased fat mass and weight gain
- Erectile dysfunction
- Diminished libido
- Night sweats
- Hair loss
- Changes in mood
At Rocky Mountain Comprehensive Health in Littleton, Colorado, we treat men’s specific health complaints.
We perform a thorough assessment and order blood work to evaluate pertinent hormone levels.
Hormone imbalances are treated with bioidentical hormones to resolve symptoms and improve a man’s quality of life.
Benefits of Bioidentical Hormones in Men:
- Helps restore optimal hormonal balance to the body
- May help men regain vitality
- May help improve blood flow
- May help increase lean muscle mass and tone
- May help improve libido and sexual performance
- May more effectively treat hypogonadism
- May stimulate sperm production
- May help increase energy levels
- May help improve concentration and memory
- May help reduce Depression
- Nourishes all tissues of urinary and reproductive system
- May help protect against heart disease
- May improve skin elasticity
- Encourages bone growth and improves bone density
- Helps accelerate fat burning
- Helps improve natural sleep cycles
- Helps maintain muscle mass
Hormone Therapy for Men
Follow-up testing is crucial to make sure that optimal levels of hormones are achieved while providing the appropriate doses of testosterone and DHEA.
Conditions where BHRT is not Recommended
Active Prostatic carcinoma, male breast cancer, unexplained prostate-specific antigen (PSA) elevation, Erythrocytosis (hematocrit >55), unstable congestive heart failure and severe untreated sleep apnea.